同一健康框架下抗菌药物替代策略及基因组学的作用
本文综述在One Health框架下减少抗菌药物使用的替代策略,包括菌群调控、畜禽育种与基因编辑、疫苗、抗毒力策略及噬菌体疗法,并指出基因组学技术有助于理解宿主-病原-菌群互作,从而推动替代方案开发和更精准的抗菌药物使用。
要点
- 减少抗菌药物使用是应对可传播耐药性上升的关键。
- 菌群调控、疫苗、抗毒力策略和噬菌体疗法是潜在替代方向。
- 基因组学有助于开发替代方案并促进抗菌药物精准使用。
核心结论
- 宿主与微生物基因组学及其他新技术对制定更健康的动物和人类疾病控制策略很重要,可减少对抗菌药物的依赖。
研究设计与样本
- 综述性文章,基于ICOHAR 2019会议讨论,聚焦One Health框架下抗菌药物替代策略及基因组学作用。
主要发现
- 减少抗菌药物使用至关重要,因可传播抗菌药物耐药性上升。
- 综述讨论了菌群调控、畜禽育种与基因编辑、疫苗接种、抗毒力策略和噬菌体疗法等替代方案。
- 基因组工具有助于更好理解宿主-病原及菌群互作,从而辅助替代方案开发。
临床怎么用
- 临床可关注基因组学技术在优化抗菌药物使用和开发替代策略中的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This review follows on from the International Conference on One Health Antimicrobial Resistance (ICOHAR 2019), where strategies to improve the fundamental understanding and management of antimicrobial resistance at the interface between humans, animals and the environment were discussed. OBJECTIVE: This review identifies alternatives to antimicrobials in a One Health context, noting how advances in genomic technologies are assisting their development and enabling more targeted use of antimicrobials. SOURCES: Key articles on the use of microbiota modulation, livestock breeding and gene editing, vaccination, antivirulence strategies and bacteriophage therapy are discussed. CONTENT: Antimicrobials are central for disease control, but reducing their use is paramount as a result of the rise of transmissible antimicrobial resistance. This review discusses antimicrobial alternatives in the context of improved understanding of fundamental host-pathogen and microbiota interactions using genomic tools. IMPLICATIONS: Host and microbial genomics and other novel technologies play an important role in devising disease control strategies for healthier animals and humans that in turn reduce our reliance on antimicrobials.
引用
- Pollock J, Low AS, McHugh RE, et al. Alternatives to antibiotics in a One Health context and the role genomics can play in reducing antimicrobial use. Clin Microbiol Infect. 2020. PMID: 32220638. doi:10.1016/j.cmi.2020.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。